Clinical Trial Update: A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase II trial of Phenoxodiol in men with prostate cancer (including castrate and non-castrate settings) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Phenoxodiol

Snippet

Sponsor: MEI Pharma, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED